The combination of thrombocytosis and JAK2/MPL/CALR mutations is highly suggestive for undiagnosed MPN or a premalignant condition, while other gene mutations seem to have no relevance in these cases. The gene discussed is MPL; the disease is myeloproliferative neoplasm.